MANDEEP BAJAJ to Non-alcoholic Fatty Liver Disease
This is a "connection" page, showing publications MANDEEP BAJAJ has written about Non-alcoholic Fatty Liver Disease.
Connection Strength
0.771
-
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association. Diabetes Care. 2025 Jul 01; 48(7):1057-1082.
Score: 0.641
-
Potential of incretin-based therapies for non-alcoholic fatty liver disease. J Diabetes Complications. 2013 Jul-Aug; 27(4):401-6.
Score: 0.068
-
Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial. Diabetologia. 2011 Dec; 54(12):3093-100.
Score: 0.062